← FDA Drug Approvals (Drugs@FDA)
POTASSIUM CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2022-03-24
Drug application
- FDA Application #
ANDA214108- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- POTASSIUM CHLORIDE
- Generic name
- POTASSIUM CHLORIDE
- Active ingredients
- POTASSIUM CHLORIDE
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- Manufacturer
- Northstar Rx LLC
- First approval
- 2022-03-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown